PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study
Abstract Background Stage III non-small cell lung cancer (NSCLC) represents a highly heterogeneous disease and treatment burden. Advances in imaging modality show promising results for radiotherapy planning. In this multicentric study, we evaluated the impact of PET/CT-based radiotherapy planning on...
Main Authors: | Matthias Mäurer, Lukas Käsmann, Daniel F. Fleischmann, Michael Oertel, Danny Jazmati, Daniel Medenwald, Young DEGRO Trial Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13014-022-01997-5 |
Similar Items
-
Lung Cancer Attributed Mortality Among 316,336 Early Stage Breast Cancer Cases Treated by Radiotherapy and/or Chemotherapy, 2000–2015: Evidence From the SEER Database
by: Semaw Ferede Abera, et al.
Published: (2021-02-01) -
Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
by: Enrique Gutiérrez, et al.
Published: (2021-07-01) -
Integrating 18F‐FDG PET/CT with lung dose‐volume for assessing lung inflammatory changes after arc‐based radiotherapy for esophageal cancer: A pilot study
by: Chen‐Xiong Hsu, et al.
Published: (2022-11-01) -
Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy.
by: Ahmad Saad , Fathinul Fikri, et al.
Published: (2010) -
Radiotherapy and Immunotherapy in Lung Cancer
by: Kristin Hsieh, et al.
Published: (2023-06-01)